Nothing but negotiation

 
The Gap Partnership

Affymetrix and eBioscience complete merger

The merger between eBioscience and Affymetrix is complete.

26 June 2012

Affymetrix may no longer be in contract negotiations regarding its acquisition of eBioscience Holding Company, as the deal has been completed.

It should increase the addressable markets held by Affymetrix by an annual sum of at least $2.5 billion (£1.6 billion), while boosting its product portfolio, with eBioscience an industry leader in the field of immunology and oncology diagnostics and oncology, as well as immunoassay reagents and flow crytometry.

President and chief executive officer of Affymetrix Dr Frank Witney explained purchasing eBioscience is an "important strategic step" for his firm.

It has provided the business with a "blue-chip portfolio of cell-based assays", he remarked, pointing out this is helping the business to diversify and identify new growth sectors.

"These new products are a critical part of our customers' workflow in our key target markets," the representative had previously noted.

Chief financial officer and executive vice-president Tim Barabe predicted the transaction will increase Affymetrix's operating income and gross margins in the fiscal year of 2012.

Posted by David Gleck

Source: Affymetrix press release, June 25th

Gap News

March 2014

The Negotiation Roadshow 2014

Generating value through creative negotiation

Read more


July 2013

Trading Global: Negotiating in the Far East

The Gap Partnership are hosting a complimentary Lunch & Learn seminar in association with UK Trade & Investment

Read more


April 2013

GroceryAid Negotiation Event Raises £26,550

The Gap Partnership, in conjunction with Asda, SC Johnson and Waitrose, host one-day negotiation workshop

Read more


February 2013

Trading Global - Negotiating in the Far East

What is the impact of cultural differences on your negotiations?

Read more


December 2012

The Gap Partnership Release New Negotiation Video

The Nothing but Negotiation video series continues with collaborative negotiation

Read more